Defining the structural and functional roles of mutations in gp120 associated with the emergence of HIV-1 clinical resistance to the CCR5 antagonist vicriviroc

被引：0
|
作者：
Howe, J. A. [1 ]
Murgolo, N. [1 ]
Hou, Y. [1 ]
Ba, L. [1 ]
Buontempo, P. [1 ]
Strizki, J. [1 ]
Ogert, R. [1 ]
机构：
[1] Schering Plough Res Inst, Dept Biol Res Virol, Kenilworth, NJ USA
来源：
ANTIVIRAL THERAPY | 2008年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A36 / A36
页数：1
相关论文
共 50 条
  • [41] Mapping of vicriviroc resistance mutations in HIV-1 gp 120 generated by in vitro selection of a primary HIV-1 isolate in PM-1 cells
    Ogert, R. A.
    Buontempo, C.
    Wojcik, L.
    Ba, L.
    Buontempo, P.
    Ralston, R. O.
    Strizki, J. M.
    Howe, J. A.
    ANTIVIRAL THERAPY, 2007, 12 : S14 - S14
  • [42] The HIV-1 gp120 interaction with Nt-CCR5-New insights from NMR
    Schnur, E.
    Scherf, T.
    Naider, F.
    Anglister, J.
    FEBS JOURNAL, 2010, 277 : 240 - 241
  • [43] Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion-incorporated CCR5
    Monde, Kazuaki
    Maeda, Yosuke
    Tanaka, Yuetsu
    Harada, Shinji
    Yusa, Keisuke
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (51) : 36923 - 36932
  • [44] R5 HIV-1 gp120 Activates p38 MAPK to Induce Rat Cardiomyocyte Injury by the CCR5 Coreceptor
    Gao, Rui
    Fang, Qiujuan
    Zhang, Xi
    Xu, Qin
    Ye, Hanhui
    Guo, Wenyan
    He, Jiao
    Chen, Yahong
    Wang, Ruixing
    Wu, Zhijuan
    Yu, Jing
    PATHOBIOLOGY, 2019, 86 (5-6) : 274 - 284
  • [45] Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding
    Wu, LJ
    LaRosa, G
    Kassam, N
    Gordon, CJ
    Heath, H
    Ruffing, N
    Chen, H
    Humblias, J
    Samson, M
    Parmentier, M
    Moore, JP
    Mackay, CR
    JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08): : 1373 - 1381
  • [46] Detection of intermolecular transferred NOEs in large protein complexes using asymmetric deuteration: HIV-1 gp120 in complex with a CCR5 peptide
    Srivastava, Gautam
    Moseri, Adi
    Kessler, Naama
    Akabayov, Sabine R.
    Arshava, Boris
    Naider, Fred
    Anglister, Jacob
    FEBS JOURNAL, 2016, 283 (22) : 4084 - 4096
  • [47] Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies
    Kuwata, Takeo
    Enomoto, Ikumi
    Baba, Masanori
    Matsushita, Shuzo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 437 - 450
  • [48] Investigating HIV-1 Resistance to CCR5 Antagonist Maraviroc for the Design of New Prevention Strategies
    Flynn, Jacqueline K.
    Roche, Michael
    Paukovics, Geza
    Salimi, Hamid
    Duncan, Renee C.
    Moore, Miranda S.
    Ellet, Anne
    Gray, Lachlan R.
    Jubb, Becky
    Westby, Mike
    Purcell, Damian F. J.
    Lewin, Sharon R.
    Lee, Benhur
    Payne, Richard J.
    Churchill, Melissa J.
    Gorry, Paul R.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A212 - A212
  • [49] Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir
    Bouba, Yagai
    Berno, Giulia
    Fabeni, Lavinia
    Carioti, Luca
    Salpini, Romina
    Aquaro, Stefano
    Svicher, Valentina
    Perno, Carlo Federico
    Ceccherini-Silberstein, Francesca
    Santoro, Maria Mercedes
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (07) : 1778 - 1786
  • [50] Evidence of HIV-1 gp120/V3-CCR5 peptide complex organization in vitro
    Rizos, A. K.
    Mpountouraki, A.
    Logakh, C.
    Samolis, P.
    Hatzidakis, G.
    Doetschman, D. C.
    Krambovitis, E.
    JOURNAL OF NON-CRYSTALLINE SOLIDS, 2011, 357 (02) : 723 - 725
12345